Pricing Log in Create free account

Edgewise Therapeutics, Inc. (EWTX) vs Tango Therapeutics, Inc. (TNGX)

Edgewise Therapeutics, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Edgewise Therapeutics, Inc. and Tango Therapeutics, Inc. are of similar size ($4.2B and $3.8B). Across the 10 metrics below, Tango Therapeutics, Inc. leads on 7 and Edgewise Therapeutics, Inc. on 3.

Valuation

Metric EWTX TNGX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 52.95 9.71
P/B 8.94 3.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 36.70 9.21
Earnings yield (4.97%) (3.81%) (33.15%)
Free cash flow yield (3.97%) (4.37%) (25.50%)

Profitability

Metric EWTX TNGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (38.03%) (21.34%) (56.36%)
Return on assets (36.09%) (18.86%) (48.04%)
Return on invested capital 0.00% (808.35%) 0.00%

Growth

Metric EWTX TNGX Biotechnology median
Revenue growth (TTM) — 48.29% 6.02%
EPS growth (last fiscal year) (12.41%) 26.89% 30.26%
Revenue growth, 5-year CAGR — 52.13% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EWTX TNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.24 50.82 4.72
Net debt to EBITDA 2.69 3.08 0.96

Dividend

Metric EWTX TNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EWTX TNGX Biotechnology median
Market cap 4.15b 3.83b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack